指南与共识头颈部肿瘤放疗

鼻咽癌CTV勾画中IIb区上界的推荐意见

Recommendation regarding the cranial upper border of level IIb in delineating clinical target volumes (CTV) for nasopharyngeal carcinoma.
指南 / 共识 · Radiat Oncol · 2020-11-23

该研究基于331例接受IMRT的非转移性鼻咽癌患者,分析颈部淋巴结转移分布,发现IIb区转移者中13.7%转移淋巴结上界超过C1下缘,修改IIb区上界后腮腺D50和V26显著降低(P=0.000),推荐个体化缩小IIb区上界以保护腮腺。

要点

  • IIb区转移者中13.7%转移淋巴结上界超过C1下缘
  • 修改IIb区上界后腮腺D50和V26显著降低(P=0.000)
  • 原则上IIb区上界应达侧颅底,特定患者可个体化缩小

核心结论

  • 原则上鼻咽癌颈部CTV勾画时IIb区上界应达侧颅底,为保护腮腺对符合特定标准的患者推荐个体化缩小IIb区上界。

研究设计与样本

  • 回顾性纳入2012至2016年331例接受IMRT的非转移性鼻咽癌患者,按AJCC第8版分期:I期15例、II期76例、III期103例、IV期137例。
  • 基于影像评估颈部淋巴结分布,使用SPSS 25.0和R 2.14.2软件比较缩小与未缩小IIb区大小患者的安全性和腮腺剂量参数。

主要发现

  • 最常受累的淋巴结为咽后外侧组和IIb组,转移率分别为82.8%和64.0%。
  • 在IIb区受累患者中,13.7%的转移淋巴结上界超过C1下缘。
  • 修改用于勾画CTV的IIb区上界后,腮腺D50和V26值显著降低(P=0.000)。

关键数值与推荐

  • IIb区受累患者中13.7%转移淋巴结上界超过C1下缘。
  • 修改IIb区上界后腮腺D50和V26显著降低(P=0.000)。

临床怎么用

  • 鼻咽癌颈部CTV勾画时IIb区上界原则上应达侧颅底。
  • 对符合特定标准的患者可个体化缩小IIb区上界以保护腮腺。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To recommend a cranial border for level IIb in delineating clinical target volumes (CTV) for nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy and to help reach a consensus on contouring level IIb in CTV. METHODS: From 2012 to 2016, 331 nonmetastatic NPC patients treated with IMRT were retrospectively enrolled. Based on the AJCC 8th staging system of NPC, there were 15 stage I, 76 stage II, 103 stage III, and 137 stage IV patients. The distribution of cervical lymph nodes in NPC was assessed based on imaging. Comparisons of the safety and parotid dose parameters between patients with and without a reduction in the size of level IIb were conducted using SPSS 25.0 and R 2.14.2 software. RESULTS: Metastasis rates in the most commonly involved lymph nodes, the lateral retropharyngeal and IIb nodes, were 82.8% and 64.0%, respectively. Among patients with level IIb involvement, the upper borders of the metastatic nodes were beyond the caudal edge of C1 in 13.7% of cases. The parotid gland D50 and V26 values were significantly reduced after modifying the upper bound of level IIb used to delineate the CTV (P = 0.000). CONCLUSION: In principle, the upper bound of level IIb should reach the lateral skull base during delineation of the cervical CTV for NPC. To protect the parotid glands, however, individualized reduction of the upper bound of level IIb is recommended for patients who meet certain criteria.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wang L, Huang S, Zhang L, et al. Recommendation regarding the cranial upper border of level IIb in delineating clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiat Oncol. 2020. PMID: 33228742. doi:10.1186/s13014-020-01720-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。